TY - JOUR T1 - Posttraumatic-stress disorder, and others psychological impairment in COVID-19 surviving patients. JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.congress-2022.3325 VL - 60 IS - suppl 66 SP - 3325 AU - G L Luna Rodríguez AU - V Peláez-Hernández AU - A Orea-Tejeda AU - V Baltazar-Chávez AU - C D Ledesma-Ruíz AU - F Casarín-López AU - A Rosas-Trujillo AU - N Camacho-Mendoza AU - C Ledesma Y1 - 2022/09/04 UR - http://erj.ersjournals.com/content/60/suppl_66/3325.abstract N2 - Background: The post-COVID syndrome generates physical and respiratory complications that can be accompanied by psychological impairments, which can affect long-term mental and physical health.Objective: Know the prevalence and severity of PTSD, anxiety, and depression in surviving COVID-19 patients in a follow-up evaluation.Method: A cross-sectional descriptive study was conducted. 227 survivors COVID-19 patients participated, were assessed three months following discharge hospital. The following questionnaires were used: The Brief Davidson Trauma Scale, the General Anxiety Disorder Questionnaire, and the Patient Health Questionnaire. A descriptive and statically analysis was performed using the statistical software SPSS version 26.Results: The 64.5% of the patients were men, 60.9% required of invasive mechanical ventilation (IMV) during the hospitalization, the average age was about 48.23±14.33 years old. The 40% of the patients showed symptoms associated with PTSD, 38.4% anxiety symptoms, 36.6% depression symptoms. There were statistically significant differences between the type of treatment during hospitalization (IMV vs without IMV), in PTSD (t=2.482, df=223, p=.014, X̅ IMV= 5.21, X̅WIMV = 6.08) and anxiety (t= -2.006, df=223, p=.046, X̅IMV= 4.05, X̅WIMV=5.44).Conclusion: Survivors of COVID-19 experience a high prevalence of PTSD, anxiety, and depression even three months after discharge from hospital. Patients who did not require IMV during hospitalization experienced a high prevalence and severity of PTSD and anxiety symptoms. Screening for PTSD and other emotional disturbances should be considered in follow-up evaluations in patients discharged from the hospital.FootnotesCite this article as Eur Respir J 2022; 60: Suppl. 66, 3325.This article was presented at the 2022 ERS International Congress, in session “-”.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only). ER -